As IL‐22‐producing group 3 ILCs protect from intestinal bacterial infection, we challenged RAG2−/− mice on eRapa or Eudragit for 1 month with the flagellated bacterium C. rodentium as described (Basu et al., 2012). Here, IL22 is linked to intestinal disorder.